1. THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED ...1. THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. 2. THE PROTEIN WAS REDUCTIVELY METHYLATED PRIOR TO CRYSTALLIZATION.
解像度: 1.7→28.689 Å / Num. obs: 44621 / % possible obs: 100 % / 冗長度: 2.9 % / Biso Wilson estimate: 20.937 Å2 / Rmerge(I) obs: 0.085 / Rsym value: 0.085 / Net I/σ(I): 9.8 / Num. measured all: 128282
反射 シェル
Diffraction-ID: 1,2
解像度 (Å)
冗長度 (%)
Rmerge(I) obs
Mean I/σ(I) obs
Num. measured all
Num. unique all
Rsym value
% possible all
1.7-1.74
2.9
0.498
1.8
9519
3320
0.498
100
1.74-1.79
2.9
0.419
1.8
9290
3225
0.419
100
1.79-1.84
2.9
0.329
2.2
8957
3118
0.329
100
1.84-1.9
2.9
0.27
2.7
8746
3041
0.27
100
1.9-1.96
2.9
0.227
3.2
8548
2955
0.227
100
1.96-2.03
2.9
0.178
4
8205
2849
0.178
100
2.03-2.11
2.9
0.163
4.2
7875
2729
0.163
100
2.11-2.19
2.9
0.139
4.9
7698
2671
0.139
100
2.19-2.29
2.9
0.116
5.7
7244
2518
0.116
100
2.29-2.4
2.9
0.104
6.4
6980
2410
0.104
100
2.4-2.53
2.9
0.095
6.7
6666
2316
0.095
100
2.53-2.69
2.9
0.088
7
6325
2199
0.088
100
2.69-2.87
2.9
0.079
7.2
5798
2021
0.079
100
2.87-3.1
2.8
0.073
7.8
5527
1940
0.073
100
3.1-3.4
2.8
0.065
8.5
4924
1733
0.065
100
3.4-3.8
2.9
0.06
8.8
4563
1588
0.06
100
3.8-4.39
2.9
0.058
8.2
4031
1406
0.058
100
4.39-5.38
2.9
0.061
8
3350
1174
0.061
100
5.38-7.6
2.9
0.064
8.1
2621
908
0.064
100
7.6-28.689
2.8
0.064
7.1
1415
500
0.064
98.4
-
位相決定
位相決定
手法: 多波長異常分散
-
解析
ソフトウェア
名称
バージョン
分類
NB
REFMAC
5.2.0019
精密化
PHENIX
精密化
SHELX
位相決定
MolProbity
3beta29
モデル構築
SCALA
3.2.5
データスケーリング
PDB_EXTRACT
3.006
データ抽出
MAR345
CCD
データ収集
MOSFLM
データ削減
SHELXD
位相決定
autoSHARP
位相決定
精密化
構造決定の手法: 多波長異常分散 / 解像度: 1.7→28.689 Å / Cor.coef. Fo:Fc: 0.952 / Cor.coef. Fo:Fc free: 0.929 / Occupancy max: 1 / Occupancy min: 0.07 / SU B: 4.127 / SU ML: 0.072 / TLS residual ADP flag: LIKELY RESIDUAL / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.105 / ESU R Free: 0.105 立体化学のターゲット値: MAXIMUM LIKELIHOOD WITH PHASES 詳細: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE ...詳細: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 3. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 4. LYSINES 71,84,182 APPEAR TO HAVE BEEN PROTECTED FROM REDUCTIVE METHYLATION AND WERE MODELED AS LYSINE IN BOTH CHAINS. ALL OTHER LYSINES HAVE BEEN MODELED AS MLY (N-DIMETHYL-LYSINE). 5. CYS27 IS OXIDIZED AS CYSTEINE SULFONIC ACID (OCS).
Rfactor
反射数
%反射
Selection details
Rfree
0.223
2298
5.2 %
RANDOM
Rwork
0.187
42321
-
-
obs
0.189
44619
99.98 %
-
溶媒の処理
イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: MASK